The chelation of technetium and rhenium has been explored to create complexes for radiopharmaceutical applications. Lastly, complexation of Re and Tc using a tetradentate diphosphinedithiol (DPDT) ligand was explored in order to determine whether or not the reducing abilities of the P 2 S 2 donor system would aid in the stability of rhenium in the +5 oxidation state. Synthesis of ReO(DPDT) led to the formation of a highly stable Re (V) complex, which remained stable in oxidative environments over a period of 5 months. Macroscale reactions using the DPDT ligand to synthesize the 99 Tc counterpart led to the formation of Tc (III) complexes directly from Tc (VII).
tissues. The complexes use tridentate, bifunctional chelating agents (BFCAs) to chelate the 99m Tc(CO) 3 + core while tethering it to an antagonist somatostatin receptor-seeking peptide (sst 2 -ANT).
The histidine-derived tridentate BFCAs used either an [N,S,N] Lastly, complexation of Re and Tc using a tetradentate diphosphinedithiol (DPDT) ligand was explored in order to determine whether or not the reducing abilities of the P 2 S 2 donor system would aid in the stability of rhenium in the +5 oxidation state. Synthesis of ReO(DPDT) led to the formation of a highly stable Re (V) complex, which remained stable in oxidative environments over a period of 5 months. Macroscale reactions using the DPDT ligand to synthesize the 99 Tc counterpart led to the formation of Tc (III) complexes directly from Tc (VII).
